Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details)

v3.20.2
Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details) - $ / shares
 3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Equity [Abstract]    
Number of Shares Outstanding, beginning balance 579,584 580,171
Number of Shares, Granted
Number of Shares, Exercised (4,437)
Number of Shares, Forfeited and cancelled (1,751) (4,313)
Number of Shares Outstanding, ending balance 577,833 571,421
Number of Shares Exercisable, ending balance 482,300 339,420
Weighted Average Exercise Price Outstanding, beginning balance $ 11.00 $ 11.05
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised 4.69
Weighted Average Exercise Price, Forfeited and cancelled 13.60 10.34
Weighted Average Exercise Price Outstanding, ending balance 10.99 11.10
Weighted Average Exercise Price Exercisable, ending balance $ 10.79 $ 10.32
Weighted Average Remaining Contract Term (years) Outstanding, beginning balance 7 years 6 months 18 days 8 years 7 months 2 days
Weighted Average Remaining Contract Term (years) Outstanding, ending balance 7 years 2 months 19 days 8 years 3 months 22 days
Weighted Average Remaining Contract Term (years) Exercisable, ending balance 6 years 11 months 26 days 7 years 10 months 3 days